Plain-English translation of NCT04999228 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether children with newly diagnosed, moderate to severe ulcerative colitis do better when they start (a powerful biologic medication) right away, or when they begin with and step up to stronger treatments only if needed. The goal is to see which approach helps children recover faster, keep their colon, and stay symptom-free longer.
Children with severe ulcerative colitis have a higher risk of needing surgery to remove their colon than adults do. Doctors think starting the medication early—before the disease gets worse—might prevent surgery and improve long-term outcomes, but no one has directly tested whether jumping to a strong medication first works better than the traditional gradual approach.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: one starting right away, or one starting first. You'll have visits at weeks 2, 6, 10, and 12 to check how well the treatment is working and how your bowel is healing. The research team will also follow you for a full year to see how long you stay symptom-free and whether you have any flare-ups.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
China